127 related articles for article (PubMed ID: 36517861)
1. Costs associated with adverse events from remission induction for children with Acute Lymphoblastic Leukemia (ALL).
Mejía-Aranguré E; Reyes-López A; Juárez-Villegas LE; Hernández-Olivares YO; Saucedo-Campos AD; Hernández-Pliego G; Martínez-Valverde S; Barajas-Nava LA; Garduño-Espinosa J
BMC Health Serv Res; 2022 Dec; 22(1):1522. PubMed ID: 36517861
[TBL] [Abstract][Full Text] [Related]
2. An economic evaluation of perioperative adverse events associated with spinal surgery.
Hellsten EK; Hanbidge MA; Manos AN; Lewis SJ; Massicotte EM; Fehlings MG; Coyte PC; Rampersaud YR
Spine J; 2013 Jan; 13(1):44-53. PubMed ID: 23384882
[TBL] [Abstract][Full Text] [Related]
3. Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.
Mungle T; Das N; Pal S; Gogoi MP; Das P; Ghara N; Ghosh D; Arora RS; Bhakta N; Saha V; Krishnan S
Cancer Med; 2023 Feb; 12(3):3499-3508. PubMed ID: 36812120
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the healthcare costs associated with adverse events in patients with breast cancer.
Wang LC; Chen HM; Chen JH; Lin YC; Ko Y
Int J Health Plann Manage; 2021 Sep; 36(5):1465-1475. PubMed ID: 33914358
[TBL] [Abstract][Full Text] [Related]
5. Hospital and home chemotherapy for children with leukemia: a randomized cross-over study.
Stevens B; Croxford R; McKeever P; Yamada J; Booth M; Daub S; Gafni A; Gammon J; Greenberg M
Pediatr Blood Cancer; 2006 Sep; 47(3):285-92. PubMed ID: 16200556
[TBL] [Abstract][Full Text] [Related]
6. Medication errors in a cohort of pediatric patients with acute lymphoblastic leukemia on remission induction therapy in a tertiary care hospital in Mexico.
Vázquez-Cornejo E; Morales-Ríos O; Juárez-Villegas LE; Islas Ortega EJ; Vázquez-Estupiñán F; Garduño-Espinosa J
Cancer Med; 2019 Oct; 8(13):5979-5987. PubMed ID: 31445000
[TBL] [Abstract][Full Text] [Related]
7. Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors.
Lin J; Makenbaeva D; Lingohr-Smith M; Bilmes R
J Med Econ; 2017 Jul; 20(7):687-691. PubMed ID: 28287043
[TBL] [Abstract][Full Text] [Related]
8. High burden of clinically significant adverse events associated with contemporary therapy for pediatric T-cell acute lymphoblastic leukemia/lymphoma.
Summers RJ; Monroig VM; DeGroote NP; West ZE; Katafias E; Miller TP
Pediatr Blood Cancer; 2023 Nov; 70(11):e30571. PubMed ID: 37440329
[TBL] [Abstract][Full Text] [Related]
9. Excess length of stay and economic consequences of adverse events in Dutch hospital patients.
Hoogervorst-Schilp J; Langelaan M; Spreeuwenberg P; de Bruijne MC; Wagner C
BMC Health Serv Res; 2015 Dec; 15():531. PubMed ID: 26626729
[TBL] [Abstract][Full Text] [Related]
10. Adverse Events and Patient Outcomes Among Hospitalized Children Cared for by General Pediatricians vs Hospitalists.
Atkinson MK; Schuster MA; Feng JY; Akinola T; Clark KL; Sommers BD
JAMA Netw Open; 2018 Dec; 1(8):e185658. PubMed ID: 30646280
[TBL] [Abstract][Full Text] [Related]
11. Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.
Sun W; Orgel E; Malvar J; Sposto R; Wilkes JJ; Gardner R; Tolbert VP; Smith A; Hur M; Hoffman J; Rheingold SR; Burke MJ; Wayne AS
Pediatr Blood Cancer; 2016 Nov; 63(11):1943-8. PubMed ID: 27437864
[TBL] [Abstract][Full Text] [Related]
12. Unit cost of healthcare services at 200-bed public hospitals in Myanmar: what plays an important role of hospital budgeting?
Than TM; Saw YM; Khaing M; Win EM; Cho SM; Kariya T; Yamamoto E; Hamajima N
BMC Health Serv Res; 2017 Sep; 17(1):669. PubMed ID: 28927450
[TBL] [Abstract][Full Text] [Related]
13. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy.
Meenan CK; Kelly JA; Wang L; Ritchey AK; Maurer SH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27515. PubMed ID: 30362242
[TBL] [Abstract][Full Text] [Related]
14. Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico.
Vázquez-Cornejo E; Morales-Ríos O; Hernández-Pliego G; Cicero-Oneto C; Garduño-Espinosa J
PLoS One; 2022; 17(3):e0265450. PubMed ID: 35324939
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of rituximab in addition to standard of care chemotherapy for adult patients with acute lymphoblastic leukemia.
Nam J; Milenkovski R; Yunger S; Geirnaert M; Paulson K; Seftel M
J Med Econ; 2018 Jan; 21(1):47-59. PubMed ID: 28837377
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
[No Abstract] [Full Text] [Related]
17. Hyperglycemia requiring insulin during acute lymphoblastic leukemia induction chemotherapy is associated with increased adverse outcomes and healthcare costs.
McCormick MC; Sharp E; Kalpatthi R; Zullo J; Gurtunca N; Zhang J; Krafty R; Raman S
Pediatr Blood Cancer; 2020 Sep; 67(9):e28475. PubMed ID: 32589365
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States.
Latremouille-Viau D; Chang J; Guerin A; Shi S; Wang E; Yu J; Ngai C
J Med Econ; 2017 Jan; 20(1):54-62. PubMed ID: 27603498
[TBL] [Abstract][Full Text] [Related]
19. Adverse events associated with Pegaspargase biosimilar in pediatric patients with acute lymphoblastic leukemia: A prospective single-center study.
Panda BK; Gaikwad M; Bafna V; Vaidya N; Aundhe V; Mhatre A
J Oncol Pharm Pract; 2023 Jul; ():10781552231190827. PubMed ID: 37501538
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in Japan.
Wakase S; Teshima T; Zhang J; Ma Q; Watanabe Y; Yang H; Qi CZ; Chai X; Xie Y; Wu EQ; Igarashi A
Transplant Cell Ther; 2021 Mar; 27(3):241.e1-241.e11. PubMed ID: 33781519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
